resveratrol has been researched along with atorvastatin in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 4 (44.44) | 2.80 |
| Authors | Studies |
|---|---|
| Bansal, SS; Ferrari, M; Ferrati, S; Filipini, S; Filippini, S; Fine, D; Grattoni, A; Nicolov, E; Palapattu, G; Raghuwansi, K; Sih, J; Zabre, E | 1 |
| Berbée, JF; Havekes, LM; Hiemstra, PS; Khedoe, PP; Mol, IM; Princen, HM; Rensen, PC; Romijn, JA; Tsikas, D; van der Hoorn, JW; van Klinken, JB; Wang, Y; Wong, MC | 1 |
| Dinesh, N; Kaur, PK; Kishore Babu, N; Pallerla, DS; Singh, S | 1 |
| Babin, PJ; Banneau, G; Benyounes, I; Castelnovo, G; Coupry, I; Debs, R; Durr, A; Ewenczyk, C; Goizet, C; Guissart, C; Hajage, D; Humbert, L; Labauge, P; Lafourcade, A; Lamari, F; Lavie, J; Lesca, G; Marelli, C; Mochel, F; Monin, ML; Odent, S; Ollagnon, E; Petit, E; Pilliod, J; Rainteau, D; Stevanin, G; Thauvin-Robinet, C; Ullmann, U; Wolf, C | 1 |
| Dulak, J; Florczyk-Soluch, U; Frołow, M; Józkowicz, A; Kachamakova-Trojanowska, N; Klóska, D; Markiewicz, J; Niżankowski, R; Nowak, WN; Stępniewski, J; Taha, H; Walter, Z | 1 |
| Chen, C; Chen, J; Dou, K; Song, C; Yin, D; Zhang, D; Zhang, R | 1 |
| Attalah Nee Rezkallah, C; Chen, QM; Thongkum, A; Zhu, C | 1 |
| Ayen, E; Bahrami, A; Behfar, M; Razi, M | 1 |
| Bahreini, E; Barzin Tond, S; Fadaei, R; Fallah, S; Farahmandian, N; Karima, S; Koushki, M; Nourbakhsh, M; Rezaei, A; Yarahmadi, S | 1 |
1 trial(s) available for resveratrol and atorvastatin
| Article | Year |
|---|---|
Plasma oxysterols: biomarkers for diagnosis and treatment in spastic paraplegia type 5.
Topics: Adolescent; Adult; Anticholesteremic Agents; Atorvastatin; Bile Acids and Salts; Child; Cholesterol; Cohort Studies; Cytochrome P450 Family 7; Deoxycholic Acid; Female; Humans; Hydroxycholesterols; Infant; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Neurologic Examination; Oxysterols; Resveratrol; ROC Curve; Spastic Paraplegia, Hereditary; Steroid Hydroxylases; Young Adult | 2018 |
8 other study(ies) available for resveratrol and atorvastatin
| Article | Year |
|---|---|
Characterization of nanochannel delivery membrane systems for the sustained release of resveratrol and atorvastatin: new perspectives on promoting heart health.
Topics: Anticholesteremic Agents; Atorvastatin; Cell Line; Cell Survival; Diffusion; Drug Delivery Systems; Drug Implants; Equipment Design; Heptanoic Acids; Humans; Membranes, Artificial; Nanostructures; Pyrroles; Resveratrol; Stilbenes; Vasodilator Agents | 2013 |
Resveratrol protects against atherosclerosis, but does not add to the antiatherogenic effect of atorvastatin, in APOE*3-Leiden.CETP mice.
Topics: Animals; Atherosclerosis; Atorvastatin; Biomarkers; Cholesterol, Dietary; Cholesterol, LDL; Drug Synergism; Female; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Mice; Mice, Transgenic; Oxidative Stress; Pyrroles; Resveratrol; Stilbenes | 2013 |
Exploring Leishmania donovani 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) as a potential drug target by biochemical, biophysical and inhibition studies.
Topics: Amino Acid Sequence; Atorvastatin; Cholesterol; Cloning, Molecular; DNA, Protozoan; Drug Delivery Systems; Ergosterol; Gene Expression Regulation, Enzymologic; Genes, Protozoan; Heptanoic Acids; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leishmania donovani; Molecular Sequence Data; Open Reading Frames; Protein Structure, Secondary; Pyrroles; Recombinant Proteins; Resveratrol; Sequence Analysis, DNA; Simvastatin; Stilbenes | 2014 |
Atorvastatin and Conditioned Media from Atorvastatin-Treated Human Hematopoietic Stem/Progenitor-Derived Cells Show Proangiogenic Activity
Topics: AC133 Antigen; Antigens, CD34; Aspirin; Atorvastatin; Cells, Cultured; Culture Media, Conditioned; Hematopoietic Stem Cells; Heme Oxygenase-1; Humans; Immunoassay; Isothiocyanates; Leukocytes, Mononuclear; Metformin; Neovascularization, Physiologic; Phenotype; Resveratrol; Sulfoxides | 2019 |
Effect of resveratrol combined with atorvastatin on re-endothelialization after drug-eluting stents implantation and the underlying mechanism.
Topics: Animals; Aorta, Abdominal; Atorvastatin; Blood Vessel Prosthesis Implantation; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug-Eluting Stents; Endothelium, Vascular; Hylobatidae; Male; MAP Kinase Signaling System; Mesenchymal Stem Cells; Microscopy, Electron, Scanning; Rabbits; Rats; Rats, Sprague-Dawley; Resveratrol; Tomography, Optical Coherence | 2020 |
Resveratrol for protection against statin toxicity in C2C12 and H9c2 cells.
Topics: Animals; Atorvastatin; Caspase 3; Caspase 7; Cell Line; Cell Survival; Fluvastatin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Mice; Myoblasts; Pravastatin; Protective Agents; Rats; Resveratrol; Signal Transduction; Simvastatin | 2020 |
Effects of atorvastatin and resveratrol against the experimental endometriosis; evidence for glucose and monocarboxylate transporters, neoangiogenesis.
Topics: Animals; Atorvastatin; Endometriosis; Excitatory Amino Acid Transporter 2; Female; Glucose; Glucose Transporter Type 3; Glycolysis; Monocarboxylic Acid Transporters; Muscle Proteins; Neovascularization, Pathologic; Rats; Rats, Wistar; Resveratrol; Symporters | 2021 |
Therapeutic Potential of Resveratrol and Atorvastatin Following High-Fat Diet Uptake-Induced Nonalcoholic Fatty Liver Disease by Targeting Genes Involved in Cholesterol Metabolism and miR33.
Topics: Animals; Atorvastatin; ATP Binding Cassette Transporter 1; Cholesterol; Diet, High-Fat; Lipoproteins, LDL; Liver X Receptors; Mice; MicroRNAs; Non-alcoholic Fatty Liver Disease; Resveratrol | 2023 |